| 539.94 4.52 (0.84%) | 04-25 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 634.22 | 1-year : | 740.77 |
| Resists | First : | 543 | Second : | 634.22 |
| Pivot price | 528.65 |
|||
| Supports | First : | 525.62 | Second : | 514.88 |
| MAs | MA(5) : | 531.9 |
MA(20) : | 530.56 |
| MA(100) : | 501.5 |
MA(250) : | 454.12 |
|
| MACD | MACD : | 1.4 |
Signal : | 0.8 |
| %K %D | K(14,3) : | 75.1 |
D(3) : | 60.4 |
| RSI | RSI(14): 60.4 |
|||
| 52-week | High : | 543 | Low : | 352.33 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ MCK ] has closed below upper band by 2.1%. Bollinger Bands are 14.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 542.6 - 544.2 | 544.2 - 546 |
| Low: | 529.78 - 531.77 | 531.77 - 533.99 |
| Close: | 536.45 - 539.44 | 539.44 - 542.79 |
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Wed, 24 Apr 2024
McKesson Corp. stock outperforms competitors on strong trading day - MarketWatch
Wed, 24 Apr 2024
McKesson Corporation Declares Quarterly Dividend - Business Wire
Tue, 23 Apr 2024
McKesson Corp. stock rises Tuesday, still underperforms market - MarketWatch
Mon, 22 Apr 2024
McKesson Corp. stock rises Monday, still underperforms market - MarketWatch
Fri, 19 Apr 2024
Why McKesson (MCK) is a Top Value Stock for the Long-Term - Zacks Investment Research
Fri, 29 Mar 2024
With 88% institutional ownership, McKesson Corporation (NYSE:MCK) is a favorite amongst the big guns - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 131 (M) |
| Shares Float | 131 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 88.4 (%) |
| Shares Short | 1,460 (K) |
| Shares Short P.Month | 1,500 (K) |
| EPS | 22.1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -15.62 |
| Profit Margin | 0.9 % |
| Operating Margin | 0.8 % |
| Return on Assets (ttm) | 3.6 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 14.8 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 2294.42 |
| EBITDA (p.s.) | 32.56 |
| Qtrly Earnings Growth | -42.3 % |
| Operating Cash Flow | 3,490 (M) |
| Levered Free Cash Flow | 3,030 (M) |
| PE Ratio | 24.43 |
| PEG Ratio | 1.7 |
| Price to Book value | -34.57 |
| Price to Sales | 0.23 |
| Price to Cash Flow | 20.33 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|